hyperprolactinemia/obesity

Lyen an sove nan clipboard la

Chwazi kalite sòt

Paj 1 soti nan 182 rezilta yo

Hyperprolactinemia in obese as well as in lean females of Koletsky rats: effect of long lasting terguride treatment.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Plasma prolactin was measured in genetically hypertensive obese Koletsky rats, in their lean siblings and in normotensive rats of Wistar strain. Lean as well as obese females show hyperprolactinemia. The males of Wistar strain as well as obese rats and their siblings show comparable prolactinemia

Is hyperprolactinemia associated with insulin resistance in non-obese patients with polycystic ovary syndrome?

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Insulin resistance is common in polycystic ovary syndrome (PCOS). Moderate elevations in serum PRL concentration may contribute to insulin resistance in PCOS. The aim of this study was to determine PRL on development of insulin resistance in non-obese hyperprolactinemic patients with PCOS.

NUTRITIONAL AND METABOLIC ASSESSMENT IN OVERWEIGHT PATIENTS WITH AND WITHOUT HYPERPROLACTINEMIA CAUSED BY PROLACTINOMA.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND prolactinomas are pituitary adenomas that express and secrete prolactin. These patients are overweight and the mechanisms are being studied. OBJECTIVE assess nutritional and metabolic status of overweight patients with and without hyperprolactinemia caused by prolactinoma and compare

Effects of glucose load and/or arginine on insulin and growth hormone secretion in hyperprolactinemia and obesity.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

In hyperprolactinemic patients an exaggerated glucose-induced insulin secretion has been reported, but these results have not been confirmed by other researchers. On the other hand, there are few data concerning somatotrope secretion in this condition. In order to clarify these points, in seven

The influences of hyperprolactinemia and obesity on cardiovascular risk markers: effects of cabergoline therapy.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE In view of the association of hyperprolactinaemia with insulin resistance, we hypothesized that patients with hyperprolactinaemia may present increased cardiovascular risk markers. METHODS Descriptive clinical trial. METHODS Serum glucose, insulin, insulin resistance, lipids, high

The influences of hyperprolactinaemia and obesity on cardiovascular risk markers: effects of cabergoline therapy.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Author's reply: the influences of hyperprolactinaemia and obesity on cardiovascular risk markers: effects of cabergoline therapy.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

[Do hyperprolactinemia and obesity affect the pulsatile hypophyseal secretion of LH and GH].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

[Evaluation of overweight, hyperprolactinaemia and suspected Cushing's syndrome].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Potential control of antipsychotic-induced hyperprolactinemia and obesity in children and adolescents by aripiprazole.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Hyperprolactinaemia as a result of immaturity or regression: the concept of maternal subroutine. A new model of psychoendocrine interactions.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Pathological hyperprolactinaemia (PH) is significantly associated with: (1) paternal deprivation during childhood, (2) depression, (3) non-specific symptoms including obesity and weight gain. The clinical onset of the symptoms often follows pregnancy or a loss. Prolactin is an insulin antagonist

Prevalence of hyperprolactinemia and thyroid disorders among patients with abnormal uterine bleeding.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE To evaluate the prevalence of hyperprolactinemia and thyroid disorders among patients with abnormal uterine bleeding (AUB) compared with matched controls. METHODS In 2013-2014, an observational study of women with AUB (group A) and women with regular menstruation (group B) was undertaken

Retrospective Analysis of Cushing's Disease with or without Hyperprolactinemia.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Objective. We compared the characteristics of patients with Cushing's disease alone with those of patients with Cushing's disease and hyperprolactinemia. Methods. Eighty-four patients were enrolled between 2002 and 2011, in a hospital in China. Clinical, endocrinological, and histopathological data,

The clinical and biochemical characteristics associated with insulin resistance in non-obese young women.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE The aim of this study was to investigate the biomarkers of insulin resistance in non-obese women. METHODS This was a retrospective study. METHODS A total 229 non-obese women (Body mass index: BMI < 25) were evaluated. METHODS Serum levels of various androgens, cardiovascular risk and

Serum prolactin concentrations in relation to hypopituitarism and obesity in children with optic nerve hypoplasia.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE The majority of children with optic nerve hypoplasia (ONH) develop hypopituitarism and many also become obese. These associated conditions are a major cause of morbidity and are possibly due to hypothalamic dysfunction. Because mild hyperprolactinemia often occurs in subjects with

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye